Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study

J Junzhe Yi J Jiongliang Wang Y Yimin Zhang X Xiongying Jiang S Song Chen (Department of Applied Physics, School of Medical Imaging) J Jie Xu X Xintong Wu S Suixing Zhong Q Qifeng Chen (Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, West China School of Pharmacy) Y Yue Hu Y Yujia Song G Genjun Tan Y Yunan Zhang J Jibin Li (Department of Clinical Research, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China) M Ming Zhao N Ning Lyu